Mechanistic studies have demonstrated that SFRP5 can inhibit myocardial inflammation and injury following a mouse model of ischemia/reperfusion injury [9], possibly exerting anti-inflammatory action via inhibition of Wnt5a. Here, SFRP5 is linked to ischemia.